A transplantable tumor model allowing investigation of NY-BR-1-specific T cell responses in HLA-DRB1*0401 transgenic mice.
Saved in:
| Title: | A transplantable tumor model allowing investigation of NY-BR-1-specific T cell responses in HLA-DRB1*0401 transgenic mice. |
|---|---|
| Authors: | Das K; Research Group GMP & T Cell Therapy, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Division of Virology, Innsbruck Medical University, Innsbruck, Austria.; Faculty of Biosciences, University Heidelberg, Heidelberg, Germany., Eisel D; Research Group GMP & T Cell Therapy, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Faculty of Biosciences, University Heidelberg, Heidelberg, Germany.; Biopharmaceutical New Technologies (BioNTech) Corporation, Mainz, Germany., Vormehr M; Biopharmaceutical New Technologies (BioNTech) Corporation, Mainz, Germany.; University Medical Center of the Johannes Gutenberg University, Mainz, Germany., Müller-Decker K; Core Facility Tumor Models, German Cancer Research Center (DKFZ), Heidelberg, Germany., Hommertgen A; Research Group GMP & T Cell Therapy, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Molecular & Radiation Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany., Jäger D; CCU Applied Tumor Immunity, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Medical Oncology, National Center for Tumor Diseases (NCT) and University Hospital Heidelberg, Heidelberg, Germany., Zörnig I; Department of Medical Oncology, National Center for Tumor Diseases (NCT) and University Hospital Heidelberg, Heidelberg, Germany., Feuerer M; Institute of Immunology, Regensburg Center for Interventional Immunology (RCI), University Regensburg and University Hospital Regensburg, Regensburg, Germany., Kopp-Schneider A; Department of Biostatistics, German Cancer Research Center (DKFZ), Heidelberg, Germany., Osen W; Research Group GMP & T Cell Therapy, German Cancer Research Center (DKFZ), Heidelberg, Germany., Eichmüller SB; Research Group GMP & T Cell Therapy, German Cancer Research Center (DKFZ), Heidelberg, Germany. s.eichmueller@dkfz.de. |
| Source: | BMC cancer [BMC Cancer] 2019 Sep 13; Vol. 19 (1), pp. 914. Date of Electronic Publication: 2019 Sep 13. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
